Antibodies against the paramyxovirus SV5 are not specific for cerebrospinal fluid from multiple sclerosis patients

B N McLean1, E J Thompson

  • 1Department of Neurochemistry, Institute of Neurology, London, U.K.

Insights

Researchers investigated Simian virus 5 (SV5) as a cause for multiple sclerosis (MS). Antibodies targeting SV5 were found in MS patients, but also in other neurological disorders, suggesting SV5 is unlikely to cause MS.

Area of Science:

  • Neuroimmunology
  • Virology
  • Infectious Diseases

Background:

  • The causative agent of multiple sclerosis (MS) remains unknown.
  • Paramyxoviruses, including Simian virus 5 (SV5), have been proposed as potential etiological factors in MS.
  • Investigating viral links is crucial for understanding MS pathogenesis.

Purpose of the Study:

  • To determine if Simian virus 5 (SV5) antibodies in cerebrospinal fluid are specific to multiple sclerosis.
  • To assess the etiological significance of SV5 in the development of MS.

Main Methods:

  • Antigen immunoblotting was used to detect immunoglobulin G (IgG) antibodies against SV5.
  • Cerebrospinal fluid (CSF) samples from multiple sclerosis patients were analyzed.
  • CSF samples from patients with other neurological disorders and oligoclonal banding were included for comparison.

Main Results:

  • Immunoglobulin G (IgG) antibodies binding to SV5 were detected in 58% of multiple sclerosis patients.
  • SV5-binding antibodies were also found in 70% of patients with various neurological disorders exhibiting oligoclonal banding.
  • The presence of SV5 antibodies was not specific to multiple sclerosis.

Conclusions:

  • The antibodies detected against SV5 in cerebrospinal fluid are not unique to multiple sclerosis patients.
  • The findings suggest that SV5 is unlikely to be an etiological agent responsible for causing multiple sclerosis.
  • Further research is needed to identify the true causative agents of MS.